Works matching IS 1021335X AND DT 2024 AND VI 51 AND IP 3
Results: 16
Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8712
- By:
- Publication type:
- Article
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8711
- By:
- Publication type:
- Article
[Retracted] miR‑17‑5p promotes the growth of osteosarcoma in a BRCC2‑dependent mechanism.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8710
- By:
- Publication type:
- Article
Enhancing the therapeutic efficacy of NK cells in the treatment of ovarian cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8709
- By:
- Publication type:
- Article
[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triple‑negative breast cancer through the regulation of pyroptosis.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8708
- By:
- Publication type:
- Article
The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8707
- By:
- Publication type:
- Article
[Retracted] MicroRNA‑520a attenuates proliferation of Raji cells through inhibition of AKT1/NF‑κB and PERK/eIF2α signaling pathway.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8706
- By:
- Publication type:
- Article
Advances in artificial intelligence for the diagnosis and treatment of ovarian cancer (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8705
- By:
- Publication type:
- Article
Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8704
- By:
- Publication type:
- Article
[Corrigendum] PRIMA‑1<sup>met</sup> induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK‑ULK1‑Vps34 signaling cascade.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8703
- By:
- Publication type:
- Article
[Retracted] Effect of RhoC on the epithelial‑mesenchymal transition process induced by TGF‑β1 in lung adenocarcinoma cells.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8702
- By:
- Publication type:
- Article
Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review).
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8701
- By:
- Publication type:
- Article
Selective degradation of PL2L60 by metabolic stresses‑induced autophagy suppresses multi‑cancer growth.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8700
- By:
- Publication type:
- Article
[Corrigendum] miR‑146b‑5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll‑like receptor 4 via the nuclear factor‑κB pathway.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8699
- By:
- Publication type:
- Article
Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8698
- By:
- Publication type:
- Article
[Retracted] AdipoR1‑mediated miR‑3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway.
- Published in:
- Oncology Reports, 2024, v. 51, n. 3, p. N.PAG, doi. 10.3892/or.2024.8697
- By:
- Publication type:
- Article